JP2021511047A5 - - Google Patents
Info
- Publication number
- JP2021511047A5 JP2021511047A5 JP2020539779A JP2020539779A JP2021511047A5 JP 2021511047 A5 JP2021511047 A5 JP 2021511047A5 JP 2020539779 A JP2020539779 A JP 2020539779A JP 2020539779 A JP2020539779 A JP 2020539779A JP 2021511047 A5 JP2021511047 A5 JP 2021511047A5
- Authority
- JP
- Japan
- Prior art keywords
- itr
- sense
- item
- expression cassette
- stranded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023116157A JP2023126487A (ja) | 2018-01-19 | 2023-07-14 | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス |
| JP2025084944A JP2025113389A (ja) | 2018-01-19 | 2025-05-21 | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862619392P | 2018-01-19 | 2018-01-19 | |
| US62/619,392 | 2018-01-19 | ||
| PCT/US2019/014122 WO2019143885A1 (en) | 2018-01-19 | 2019-01-18 | Closed-ended dna vectors obtainable from cell-free synthesis and process for obtaining cedna vectors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023116157A Division JP2023126487A (ja) | 2018-01-19 | 2023-07-14 | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021511047A JP2021511047A (ja) | 2021-05-06 |
| JP2021511047A5 true JP2021511047A5 (cg-RX-API-DMAC7.html) | 2022-02-24 |
Family
ID=67301565
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539779A Pending JP2021511047A (ja) | 2018-01-19 | 2019-01-18 | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス |
| JP2023116157A Withdrawn JP2023126487A (ja) | 2018-01-19 | 2023-07-14 | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス |
| JP2025084944A Pending JP2025113389A (ja) | 2018-01-19 | 2025-05-21 | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023116157A Withdrawn JP2023126487A (ja) | 2018-01-19 | 2023-07-14 | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス |
| JP2025084944A Pending JP2025113389A (ja) | 2018-01-19 | 2025-05-21 | 無細胞合成から得ることができる閉端DNAベクターおよびceDNAベクターを得るためのプロセス |
Country Status (16)
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020001593A (es) | 2017-08-09 | 2020-07-13 | Bioverativ Therapeutics Inc | Moleculas de acido nucleico y usos de las mismas. |
| AU2019221642A1 (en) * | 2018-02-14 | 2020-07-09 | Generation Bio Co. | Non-viral DNA vectors and uses thereof for antibody and fusion protein production |
| JP7602454B2 (ja) | 2018-08-09 | 2024-12-18 | バイオベラティブ セラピューティクス インコーポレイテッド | 核酸分子及び非ウイルス遺伝子治療のためのそれらの使用 |
| WO2020097417A1 (en) * | 2018-11-09 | 2020-05-14 | Generation Bio Co. | Modified closed-ended dna (cedna) comprising symmetrical modified inverted terminal repeats |
| GB201905651D0 (en) | 2019-04-24 | 2019-06-05 | Lightbio Ltd | Nucleic acid constructs and methods for their manufacture |
| WO2021011842A1 (en) | 2019-07-17 | 2021-01-21 | Generation Bio Co. | Synthetic production of single-stranded adeno associated viral dna vectors |
| DE102020111571A1 (de) | 2020-03-11 | 2021-09-16 | Immatics US, Inc. | Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren |
| IL296660A (en) * | 2020-03-24 | 2022-11-01 | Generation Bio Co | Non-viral DNA vectors and their use for therapeutic expression of factor ix |
| MX2023001109A (es) | 2020-07-27 | 2023-04-24 | Anjarium Biosciences Ag | Composiciones de moleculas de adn, metodos para elaborar las mismas, y metodos de usos de las mismas. |
| US20220243201A1 (en) * | 2020-08-23 | 2022-08-04 | Bioverativ Therapeutics Inc. | Engineered itr sequences and methods of use |
| MX2023003019A (es) * | 2020-09-16 | 2023-05-08 | Generation Bio Co | Vectores de adn de extremo cerrado y usos de estos para expresar fenilalanina hidroxilasa (pah). |
| GB202014751D0 (en) | 2020-09-18 | 2020-11-04 | Lightbio Ltd | Targeting vector |
| GB202014772D0 (en) | 2020-09-18 | 2020-11-04 | Lightbio Ltd | Nucleic acid construct |
| CA3209115A1 (en) * | 2021-01-25 | 2022-07-28 | Prevail Therapeutics, Inc. | Modulation of aav-based gene expression |
| CN112980862A (zh) * | 2021-02-25 | 2021-06-18 | 通用生物系统(安徽)有限公司 | 一种高纯度微环dna的制备方法 |
| JP2024517427A (ja) | 2021-04-20 | 2024-04-22 | アンジャリウム バイオサイエンシズ エージー | アミロ-α-1,6-グルコシダーゼ、4-α-グルカノトランスフェラーゼをコードするDNA分子の組成物、その作製の方法、及びその使用の方法 |
| US20240216535A1 (en) * | 2021-04-27 | 2024-07-04 | Generation Bio Co. | Non-viral dna vectors expressing anti-coronavirus antibodies and uses thereof |
| JP2024515788A (ja) * | 2021-04-27 | 2024-04-10 | ジェネレーション バイオ カンパニー | 治療抗体を発現する非ウイルスdnaベクター及びその使用 |
| WO2022236016A1 (en) * | 2021-05-07 | 2022-11-10 | Generation Bio Co. | Lyophilized non-viral dna vector compositions and uses thereof |
| EP4333886A4 (en) * | 2021-05-07 | 2025-11-12 | Generation Bio Co | NON-VIRAL DNA VECTORS FOR VACCINE ADMINISTRATION |
| US20250049961A1 (en) * | 2021-12-23 | 2025-02-13 | Generation Bio Co. | Scalable and high-purity cell-free synthesis of closed-ended dna vectors |
| WO2023135273A2 (en) | 2022-01-14 | 2023-07-20 | Anjarium Biosciences Ag | Compositions of dna molecules encoding factor viii, methods of making thereof, and methods of use thereof |
| GB202204112D0 (en) | 2022-03-23 | 2022-05-04 | Lightbio Ltd | Linear construct |
| EP4293101A1 (en) | 2022-06-14 | 2023-12-20 | Asklepios Biopharmaceutical, Inc. | Reactor with temperature control and method of using the same |
| JP2025525583A (ja) | 2022-07-19 | 2025-08-05 | ランパート バイオサイエンス インコーポレイテッド | 非免疫原性環状非ウイルス性dnaベクター |
| WO2024040222A1 (en) | 2022-08-19 | 2024-02-22 | Generation Bio Co. | Cleavable closed-ended dna (cedna) and methods of use thereof |
| US20260199386A1 (en) * | 2022-12-01 | 2026-07-16 | Generation Bio Co. | Synthetic single-stranded dna molecules and methods of producing and using the same |
| WO2024170778A1 (en) | 2023-02-17 | 2024-08-22 | Anjarium Biosciences Ag | Methods of making dna molecules and compositions and uses thereof |
| US11993783B1 (en) * | 2023-03-27 | 2024-05-28 | Genecraft Inc. | Nucleic acid molecule comprising asymmetrically modified ITR for improving expression rate of inserted gene, and use thereof |
| WO2026085495A1 (en) | 2024-10-18 | 2026-04-23 | Generation Bio Co. | Synthetic partially single-stranded nucleic acid compositions and uses and methods therefor |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| US6346415B1 (en) * | 1997-10-21 | 2002-02-12 | Targeted Genetics Corporation | Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors |
| AU2002365514A1 (en) | 2001-11-30 | 2003-06-10 | Innogenetics N.V. | Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma |
| EP3176263A1 (en) * | 2007-08-10 | 2017-06-07 | Toto Ltd. | Method of producing recombinant mammalian cells |
| US8709778B2 (en) * | 2008-10-28 | 2014-04-29 | Xavier Danthinne | Method of adenoviral vector synthesis |
| EP2500434A1 (en) | 2011-03-12 | 2012-09-19 | Association Institut de Myologie | Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery |
| EP2970966A4 (en) * | 2013-03-15 | 2016-10-26 | Univ North Carolina | SYNTHETIC ADENOASSOZED VIRUS INVERTED REPEAT SEQUENCES |
| IL261524B2 (en) * | 2016-03-03 | 2023-10-01 | Univ Massachusetts | End-capped linear double-stranded DNA for non-viral gene transfer |
| WO2019101596A1 (en) | 2017-11-21 | 2019-05-31 | Expedeon Ltd | Methods and kits for amplification of double stranded dna |
| AU2019221642A1 (en) | 2018-02-14 | 2020-07-09 | Generation Bio Co. | Non-viral DNA vectors and uses thereof for antibody and fusion protein production |
| KR20210119416A (ko) * | 2019-01-24 | 2021-10-05 | 제너레이션 바이오 컴퍼니 | 폐쇄-말단 dna (cedna), 및 유전자 또는 핵산 치료 관련 면역 반응을 감소시키는 방법에서의 이의 용도 |
| WO2021011842A1 (en) * | 2019-07-17 | 2021-01-21 | Generation Bio Co. | Synthetic production of single-stranded adeno associated viral dna vectors |
| US20220228171A1 (en) * | 2019-07-17 | 2022-07-21 | Generation Bio Co. | Compositions and production of nicked closed-ended dna vectors |
-
2019
- 2019-01-18 JP JP2020539779A patent/JP2021511047A/ja active Pending
- 2019-01-18 US US16/962,005 patent/US12442015B2/en active Active
- 2019-01-18 MY MYPI2020003241A patent/MY208589A/en unknown
- 2019-01-18 UA UAA202005240A patent/UA130154C2/uk unknown
- 2019-01-18 MA MA051626A patent/MA51626A/fr unknown
- 2019-01-18 KR KR1020257036119A patent/KR20250159738A/ko active Pending
- 2019-01-18 BR BR112020013319-1A patent/BR112020013319A2/pt unknown
- 2019-01-18 CA CA3088984A patent/CA3088984A1/en active Pending
- 2019-01-18 MX MX2020005790A patent/MX2020005790A/es unknown
- 2019-01-18 SG SG11202005271TA patent/SG11202005271TA/en unknown
- 2019-01-18 IL IL275878A patent/IL275878B2/en unknown
- 2019-01-18 EP EP19741445.1A patent/EP3740571A4/en active Pending
- 2019-01-18 WO PCT/US2019/014122 patent/WO2019143885A1/en not_active Ceased
- 2019-01-18 KR KR1020207023526A patent/KR102879598B1/ko active Active
- 2019-01-18 AU AU2019210034A patent/AU2019210034B2/en active Active
- 2019-01-18 CN CN201980019414.XA patent/CN111868242A/zh active Pending
-
2020
- 2020-06-11 PH PH12020550878A patent/PH12020550878A1/en unknown
-
2023
- 2023-07-14 JP JP2023116157A patent/JP2023126487A/ja not_active Withdrawn
-
2025
- 2025-05-21 JP JP2025084944A patent/JP2025113389A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023126487A5 (cg-RX-API-DMAC7.html) | ||
| JP7860174B2 (ja) | 生成が改良されたウイルス及び非ウイルスのナノプラスミドベクター | |
| JP2022530544A5 (cg-RX-API-DMAC7.html) | ||
| CA3233336A1 (en) | Circular rna and preparation method thereof | |
| KR20240113624A (ko) | Aav 캡시드 변이체 및 이의 용도 | |
| JP2022530633A5 (cg-RX-API-DMAC7.html) | ||
| JP2022530656A5 (cg-RX-API-DMAC7.html) | ||
| AU2023217698A1 (en) | Aav capsid variants and uses thereof | |
| CA3092459A1 (en) | Closed-ended dna (cedna) vectors for insertion of transgenes at genomic safe harbors (gsh) in humans and murine genomes | |
| JP7481755B2 (ja) | 組換えパルボウイルスベクターならびにその作製および使用方法 | |
| JP2022529065A5 (cg-RX-API-DMAC7.html) | ||
| WO2022159402A1 (en) | Composition and method for high-multiplexed genome engineering using synthetic crispr arrays | |
| JP7489112B2 (ja) | Crisprタイプi-dシステムを利用した標的配列改変技術 | |
| WO2025102994A1 (zh) | 基于i型内含子的rna体外环化与滚环翻译的方法及其应用 | |
| CN113950530A (zh) | 核酸多联体产物的表达 | |
| CA3206298A1 (en) | Functional nucleic acid molecule and method | |
| US9012620B2 (en) | DNA constructs for specific inhibition of gene expression by RNA interference | |
| JP2025510714A (ja) | 遺伝子編集用のrnaフレームワーク及び遺伝子編集方法 | |
| AU2022399440A1 (en) | Functional aav capsids for intravitreal administration | |
| JP2024521750A5 (cg-RX-API-DMAC7.html) | ||
| AU784832B2 (en) | Self-cleaving RNA sequences and their use for the control of protein synthesis | |
| RU2020127017A (ru) | ДНК-ВЕКТОРЫ С ЗАМКНУТЫМИ КОНЦАМИ, ПОЛУЧАЕМЫЕ ПУТЕМ БЕСКЛЕТОЧНОГО СИНТЕЗА, И СПОСОБ ПОЛУЧЕНИЯ зкДНК-ВЕКТОРОВ | |
| US20260103702A1 (en) | Compositions and methods for crispr modulation | |
| WO2025072763A2 (en) | Compositions and methods for precision editing with cas dimers | |
| JP2025530419A (ja) | フォールディングオリゴヌクレオチド |